Brief: Codiak Biosciences Says Total Revenues For Quarter Ended Dec. 31, 2020 Were $1.6 Mln, Compared To $0.2 Mln For Same Period In 2019
March 17 (Reuters) - Codiak BioSciences, Inc. CDAK.O :
* CODIAK BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND OPERATIONAL PROGRESS
* CODIAK BIOSCIENCES, INC. - TOTAL REVENUES FOR QUARTER
ENDED
DECEMBER 31, 2020 WERE $1.6 MILLION, COMPARED TO $0.2 MILLION
FOR SAME PERIOD IN 2019
* CODIAK BIOSCIENCES, INC. - AS OF DECEMBER 31, 2020, CODIAK
HAD
CASH AND CASH EQUIVALENTS OF ABOUT $88.9 MILLION
Source text for Eikon: ID:nGNX62YWCj
Further company coverage: CDAK.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy